Abstract
Ensuring the clinical utility of genetic testing and understanding issues surrounding public access to this technology were among the priorities targeted for more in-depth study by a Department of Health and Human Services advisory committee. The Advisory Committee on Genetics, Health, and Society met July 7–8 in Washington, D.C., to continue working toward a final report on policy needs for the growing field of genetic and genomic testing. Mike Leavitt, secretary of Health and Human Services, said this committee can help develop information needed for policies that strike a balance between meeting consumer needs and imposing regulatory restrictions. “I think it is often the case that consumers are underestimated in terms of their capacity to sort through these things,” he said. “I think there is often a sense of well-intended protection that we want to provide that sometimes can constrain progress. Somebody needs to be pushing the envelope a little, and at the same time you have to have the brake on to keep us on the road.”
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.